Strata Critical Medical, Inc. (SRTA)
Nasdaq · Healthcare · Medical Care Facilities
$4.81+1.69%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $426M
- 52-week range
- $3.95 – $6.50
- 52-week change
- −8.16%
- EPS (trailing)
- −$0.28
- Next earnings
- Nov 9, 2026
Fiscal year to Dec 2025
- Revenue
- $197M (+34.27%)
- Net income
- $41.3M
- Operating margin
- −11.3%
- Diluted EPS
- $0.50
- Free cash flow
- −$58.5M
From the company’s annual report on SEC EDGAR.
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Headquarters: New York, United States · 327 employees · stratacritical.com